STAT+: FDA takes applications for new program to shorten drug approval times
The FDA is opening applications for a pilot program designed to shorten drug approval timelines and help the U.S. compete with countries like China and Australia.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.